BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1785913)

  • 1. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC; Rao BB
    Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S; Senthil K; Nalini N
    Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.
    Patel PS; Adhvaryu SG; Balar DB; Parikh BJ; Shah PM
    Anticancer Res; 1994; 14(2B):747-51. PubMed ID: 8010734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB; Patel PS; Chawda JG; Shah RM
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS; Rawal GN; Balar DB
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers in ovarian cancer.
    Kiricuta I; Bojan O; Munteanu S
    Arch Geschwulstforsch; 1986; 56(1):35-8. PubMed ID: 3964031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR; Tadros GH; Foemmel R; Shebes M
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of sialic acid as a tumor marker].
    Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
    Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic role of plasma and urinary sialic acid in human carcinoma of uterine cervix.
    Balasubramaniyan N; Subramanian S; Sekar N; Bhuvarahamurthy V; Govindasamy S
    Biochem Mol Biol Int; 1994 Jul; 33(4):617-23. PubMed ID: 7981648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer.
    Joshi M; Patil R
    J Cancer Res Ther; 2010; 6(3):263-6. PubMed ID: 21119250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of sialic acid in cancer of the upper aero-digestive tract].
    Galioto GB; Mevio E; Benazzo M; Galioto P
    Ann Otolaryngol Chir Cervicofac; 1986; 103(3):167-71. PubMed ID: 3752855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum fucose, sialic acid, haptoglobine and phospholipids levels in the evolution and treatment of breast cancer.
    Kiricuta I; Bojan O; Comes R; Cristian R
    Arch Geschwulstforsch; 1979; 49(2):106-12. PubMed ID: 475547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.